Diabetes
The latest diabetes and endocrinology news from UNC Health Care and the UNC School of Medicine.
To test or not to test: Blood glucose monitoring for patients with type 2 diabetes
The Patient-Centered Outcomes Research Institute awards UNC School of Medicine researchers more than $2 million to study glucose monitoring in non-insulin treated patients living with type 2 diabetes.
Diabetes investigation in rats makes editor's pick in APS journal
An investigation into diabetes-related outcomes in a rat model, with senior author William Valdar, PhD, assistant professor of genetics at UNC, and first author Leah Solberg Woods, PhD, from the Medical College of Wisconsin, has made the editor's pick in this month's Physiological Genomics, a journal of the American Physiological Society.
UNC's Dr. John Buse named to international diabetes prize selection jury
The 2013 Harold Hamm International Prize for Biomedical Research in Diabetes encourages research focused on progress toward a cure.
Head-to-head trial of two diabetes drugs yields mixed results
Daily injections of liraglutide were slightly more effective than weekly injections of exenatide in lowering blood sugar and promoting weight loss. However, patients had fewer negative side effects on exenatide once weekly.
Three UNC specialties nationally ranked by U.S. News
Overall, eleven specialties at UNC Hospitals were recognized as nationally ranked or high performing by U.S. News & World Report in its annual "America's Best Hospitals" issue.
Antibodies reverse Type 1 diabetes in new immunotherapy study
Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease.
Join Dr. John Buse for live Facebook chat on diabetes
Dr. John Buse, director of the UNC Diabetes Care Center and chair of the National Diabetes Education Program, will host a live Facebook chat on diabetes management and prevention on Tuesday, May 22.
Scientists awarded $2.4 million to study genetic variation in people with diabetes
The goal of the study is to identify genetic variations that may help predict the response to various treatment options for type 2 diabetes to reduce cardiovascular disease.
First clinic to receive NCQA Diabetes Recognition Program recertification via new electronic submission
The UNC Internal Medicine Clinic achieved recertification for the National Committee for Quality Assurance (NCQA) Diabetes Recognition Program November 2011-2014.
UNC study helps clarify link between high saturated fat diet and type 2 diabetes
New research from the University of North Carolina at Chapel Hill School of Medicine adds clarity to the connection. The study published on-line April 10th in the journal Nature Immunology finds that saturated fatty acids but not the unsaturated type can activate immune cells to produce an inflammatory protein, called interleukin-1beta.
UNC expert: Combining exenatide with insulin may be 'best result ever' for diabetes patients
A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.
Blog: One physician's take on the Avandia controversy...
When asked his thoughts about the Avandia controversy, Dr. John Buse, director of the UNC Diabetes Care Center and past president of the American Diabetes Association, had this to say…
Raleigh TCOYD Conference & Health Fair
The Taking Control of Your Diabetes Conference and Health Fair will take place on May 22.
Raleigh TCOYD Conference & Health Fair
The Taking Control of Your Diabetes Conference and Health Fair will take place on May 22.
Treating pregnant women for mild gestational diabetes reduces serious birthing problems
Treating pregnant women for mild gestational diabetes resulted in fewer cesarean sections and other serious birthing problems associated with larger than average babies, according to a study conducted in part at the University of North Carolina at Chapel Hill.
Buse to receive national award for clinical excellence
John B. Buse, MD, PhD, has been selected to receive a Clinical Excellence award at the Castle Connolly National Physician of the Year Awards ceremony.
Buse to receive national award for clinical excellence
John B. Buse, MD, PhD, has been selected to receive a Clinical Excellence award at the Castle Connolly National Physician of the Year Awards ceremony.
Scientists map out regulatory regions of genome, hot spots for diabetes genes
The research, published online Jan. 31, 2010, in the journal Nature Genetics, presents the first high-resolution atlas of these regulatory elements in the most studied cell type for treatment and prevention of type II diabetes.
Scientists map out regulatory regions of genome, hot spots for diabetes genes
The research, published online Jan. 31, 2010, in the journal Nature Genetics, presents the first high-resolution atlas of these regulatory elements in the most studied cell type for treatment and prevention of type II diabetes.
VIDEO: A1C test now recommended for diabetes screening/diagnosis
New official guidelines for diabetes screening and diagnosis now include a blood test that gives a person’s average blood glucose level over the previous 2-3 months.
